MCINNES MEDICAL CONSULTANCY LTD

🌳Matureactive
SC400440 · ltd · incorporated 2011-05-26
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
Why now
Window steady · low confidence
Stable recent picture — watch for any upcoming trigger event.
What changed my view
Last 30 days

No material changes in the last 30 days.

Last 90 days

No snapshot from 90 days ago — start tracking from today.

Last 180 days

No snapshot from 180 days ago — start tracking from today.

🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
£-1.9k
book net assets
Opportunity
80/100
Exceptional
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 64). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
4 connected companies via shared directors
57
Filing history
36 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
80/100Exceptional
PassWatchWorth a lookStrongExceptional 

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
80
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Negative net assets
Liabilities exceed assets by £1,935
Net assets shrinking
Down £25,515 YoY

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
-£2k
↓ 108% YoY
Current Assets
£8k
↓ 80% YoY
Current Liabilities
-£2k£6k£14k£23k£31k£39kMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-03-312024-03-31
Total assets£-1.9k£23.6k
Current assets£7.9k£39.0k
Net assets£-1.9k£23.6k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
1
filing
  • 1 confirmation-statement
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (18 events)Click to expand
  1. 2025-11-24
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2024-12-20
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  3. 2024-02-29
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  4. 2024-02-29
    📄
    change-person-director-company-with-change-date
    officers · CH01
  5. 2024-02-29
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  6. 2024-02-29
    📄
    change-person-director-company-with-change-date
    officers · CH01
  7. 2023-12-21
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  8. 2022-12-27
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  9. 2021-12-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  10. 2020-12-22
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  11. 2019-12-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  12. 2018-12-30
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2017-12-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  14. 2016-12-31
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  15. 2016-06-15
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  16. 2011-05-26
    🏢
    Company incorporated
    As MCINNES MEDICAL CONSULTANCY LTD
  17. 2011-05-26
    MCINNES, Iain Blair, Professor appointed
    director
  18. 2011-05-26
    MCINNES, Karin Rowena appointed
    director

Owner dependency

100/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Founder name in company name: Company name contains director surname "MCINNES" — strong identity link between founder and business.
  • +Long-tenure founder: Senior director has been in place 15 years — deep operational knowledge concentrated in one person.
  • +Senior director age: Director aged approximately 64 — approaching natural succession window.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
  • +No director turnover: Company is 15 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

79/100
Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • secondary12+ year tenure: Director in role 15 years.
  • secondaryStable-but-static management: Company is 15 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Professor Iain Blair Mcinnes
Individual · British · DOB 10/1964 · age 62
2550%
25-50% shares06/04/2016
Mrs Karin Rowena Mcinnes
Individual · British · DOB 10/1962 · age 64
2550%
25-50% shares06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · G postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
OPTICAL EXPRESS LIMITED
SC161469 · est 1995
£80.82M
£58.19M£103.45M
5490030y8558y
GP MATTERS LIMITED
SC424457 · est 2012
£3.46M
£2.49M£4.43M
50014y8561y
GATE HEALTHCARE LIMITED
SC106549 · est 1987
£2.91M
£2.09M£3.72M
17838y8260y
LORIMER CARE HOMES LIMITED
SC412450 · est 2011
£2.26M
£1.63M£2.89M
014y8260y
GLENFAIRN LIMITED
SC087540 · est 1984
£1.83M
£1.32M£2.34M
8442y8260y
ASPIRE HOUSING & PERSONAL DEVELOPMENT SERVICES LIMITED
SC231773 · est 2002
£354.7k24y8377y
BCERTA LTD.
SC355831 · est 2009
17y8367y
COMMONWEALTH DENTAL PRACTICE LTD.
SC381148 · est 2010 · no financials extracted
15y8358y
DAVID LIVINGSTONE INTERNATIONAL LIMITED
SC118899 · est 1989
£150.4k36y8390y
DOON CARE LTD.
SC262088 · est 2004
£1.46M22y8387y
DUNDONALD HOUSE NURSING HOME LIMITED
SC296431 · est 2006
20y8364y
FORWARD STEPS NURSERY LTD.
SC235287 · est 2002
£59.0k23y8359y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2011-05-26
Jurisdictionscotland
Primary SIC86220 — Specialist medical practice activities

Registered office

36 Thorn Road
Bearsden
Glasgow
G61 4BS

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2027-06-09
Last: 2026-05-26

Officers (2 active · 0 resigned)

MCINNES, Iain Blair, Professor
director · ~62y · appointed 2011-05-26
View their other companies + combined net worth →
Active
MCINNES, Karin Rowena
director · ~64y · appointed 2011-05-26
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (36 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-06-09
accounts-with-accounts-type-micro-entity
accounts · AA
2025-11-24
confirmation-statement-with-updates
confirmation-statement · CS01
2025-06-20
accounts-with-accounts-type-micro-entity
accounts · AA
2024-12-20
confirmation-statement-with-updates
confirmation-statement · CS01
2024-06-14
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-02-29
change-person-director-company-with-change-date
officers · CH01
2024-02-29
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2024-02-29
change-person-director-company-with-change-date
officers · CH01
2024-02-29
accounts-with-accounts-type-micro-entity
accounts · AA
2023-12-21
confirmation-statement-with-updates
confirmation-statement · CS01
2023-06-13
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-12-27
confirmation-statement-with-updates
confirmation-statement · CS01
2022-06-06
accounts-with-accounts-type-total-exemption-full
accounts · AA
2021-12-31
confirmation-statement-with-updates
confirmation-statement · CS01
2021-06-09